-transparent.png){kind=logo}
Imiquimod is a recently developed imidazoquinolin heterocyclic amine that is an immune response modifier. Treatment with topical 5% imiquimod cream has shown promising results in the treatment of genital warts in immunocompetent individuals. We report here the first case of successful treatment with topical 5% imiquimod cream of facial verrucae in an individual with human immunodeficiency virus.
Related Publications
K Cutler, and
M H Kagen, and
P C Don, and
P McAleer, and
J M Weinberg
January 2001,
Acta dermato-venereologica,
K Cutler, and
M H Kagen, and
P C Don, and
P McAleer, and
J M Weinberg
May 2003,
Clinical and experimental dermatology,
K Cutler, and
M H Kagen, and
P C Don, and
P McAleer, and
J M Weinberg
February 2009,
The Journal of laryngology and otology,
K Cutler, and
M H Kagen, and
P C Don, and
P McAleer, and
J M Weinberg
July 2003,
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG,
K Cutler, and
M H Kagen, and
P C Don, and
P McAleer, and
J M Weinberg
January 2007,
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
K Cutler, and
M H Kagen, and
P C Don, and
P McAleer, and
J M Weinberg
January 2011,
Acta dermatovenerologica Croatica : ADC,
K Cutler, and
M H Kagen, and
P C Don, and
P McAleer, and
J M Weinberg
September 2006,
Clinical and experimental dermatology,
K Cutler, and
M H Kagen, and
P C Don, and
P McAleer, and
J M Weinberg
January 2000,
Pediatric dermatology,
K Cutler, and
M H Kagen, and
P C Don, and
P McAleer, and
J M Weinberg
January 2003,
Pediatric dermatology,
K Cutler, and
M H Kagen, and
P C Don, and
P McAleer, and
J M Weinberg
September 2012,
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.],
